Parkinsons Congress Market Analysis and Reports | Italy Conference Series

Market Analysis - Parkinsons Congress 2020

Market Analysis

Parkinson's disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system. The symptoms generally come on slowly over time. Early in the disease, the most obvious are shaking, rigidity, slowness of movement, and difficulty with walking. Thinking and behavioral problems may also occur. Dementia becomes common in the advanced stages of the disease. Depression and anxiety are also common, occurring in more than a third of people with PD. Other symptoms include sensory, sleep, and emotional problems. The main motor symptoms are collectively called "parkinsonism", or a "parkinsonian syndrome"
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research

The Global Parkinsons Disease report published by the Ameco Research provides a detailed analysis of Parkinson’s Disease market along with the current trends and future outlook. The report covers the quantitative and qualitative data and the factors that are responsible to drive and restrain the growth of the target market. The report provides the overview of the segments and information of the key manufacturers operating in target market. The report provides the detailed overview of the industry value chain process along with the regulatory scenario for various products and services across the globe. The report includes cost structure analysis providing the overview of manufacturing expanses and labor cost required for the product

The global Parkinson's Disease market is valued at 4240 million US$ in 2018 is expected to reach 6810 million US$ by the end of 2025, growing at a CAGR of 6.1% during 2019-2025.
This report focuses on Parkinson's Disease volume and value at global level, regional level and company level. From a global perspective, this report represents overall Parkinson's Disease market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

Parkinson's Disease total prevalent population in the 7MM countries was observed to be 1,608,367 in 2019 and is growing at a CAGR of 0.54% for the study period [2019–2028] Parkinson's Disease market size was USD 1837.90 million in 2019 in the 7MM.  Among the 7 Major Markets, the United States accounted for the majority of the market size, with USD 941.13 million followed by Germany, which has the second-highest market size after the United States in 2019.

As per WHO statistics worldwide PD case are recorded 2019 year are following

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

USA

Germany

Italy

Spain

UK

France

Poland

India

Japan

PD cases recoded world wild 2019

60000

260000

200000

150000

120000

117000

140000

1,00,000

208500

 

It was observed PD cases are been increased very year worldwide research on Parkinson’s and Huntington disease are focused heavily

Huntington’s disease is an inherited condition in which nerve cells in the brain break down over time. It is a progressive brain disorder that causes uncontrolled movements, emotional problems, and loss of thinking ability (cognition). Adult-onset Huntington disease, the most common form of this disorder, usually appears in a person's thirties or forties.

 

USA

Germany

Italy

Spain

UK

France

Poland

India

Japan

Huntington's Disease  cases recoded world wild 2019

30000

160000

250000

60000

105000

127000

190000

50000

26000

 

Importance & Scope: Parkinson’s congress focuses on the rate of uptake of the potential drugs recently launched in the market or will get launched in the market during the study period from 2019-2028. The analysis covers market uptake by drugs patient uptake by therapies and sales of each drug

This helps in understating the drugs with the most rapid uptake reasons behind the maximal use of new drugs and allows the comparison of drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

Target Audience:  Parkinson’s congress target Neurologists, researchers, Therapists, counselors, Rehabilitation therapists, Psychologists, physiotherapists as speakers we also invite exhibitors to exhibit the products and services from commercial and non-commercial organizations like Drug manufactures, Clinical Trial Sites, Management Consultants, Chemists, Pharmacists, Business delegates and Equipment Manufacturers.

Related Companies/Industries:

Teva
Novartis
GSK
AbbVie
Merck
Boehringer Ingelheim
Impax
Lundbeck
Sun Pharma
Wockhardt
UCB
Valeant Pharmaceuticals
Acadia
GSK
Boehringer Ingelheim
Teva Pharmaceutical
Abbvie
Kyowa Hakko Kirin Pharma
Astellas Pharma
Desitin Arzneimittel
Endo Pharmaceuticals
F.Hoffmann-La Roche
H.Lundbeck
Valeant
Apokyn
Orion
Stada Arzneimittel
US WorldMeds
Valeant Pharmaceuticals

Market Segment by Product Type
Sinemet-CR
Trastal
Madopar
COMT Inhibitor
Other

 

Related Associations and Societies:


European Parkinson therapy centre

Better lives. Together parkinsons foundation

Parkinsons disease EBC

Parkinsons therapy and Rehabilitation center

The European Parkinson centre

Anthea Hospital – GVM International

Bozen Regioanl Hospital